Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_assertion type Assertion NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_head.
- NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_assertion description "[This has defined an important emerging role for targeting of CD30 in the setting of Hodgkin lymphoma, ALCL, and possibly other CD30+ malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_provenance.
- NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_assertion evidence source_evidence_literature NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_provenance.
- NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_assertion SIO_000772 21619423 NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_provenance.
- NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_assertion wasDerivedFrom befree-2016 NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_provenance.
- NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_assertion wasGeneratedBy ECO_0000203 NP897468.RAcAsDc2Fmta6wsNEG3nChOFhtDTdwE0W-pNTXtYrf1Gk130_provenance.